Quantitative MRI and machine learning for the diagnosis and prognosis of Multiple Sclerosis

Multiple sclerosis (MS) is an immune-mediated, inflammatory, neurological disease affecting myelin in the central nervous system, whose driving mechanisms are not yet fully understood. Conventional magnetic resonance imaging (MRI) is largely used in the MS diagnostic process, but because of its lack of specificity, it cannot reliably detect microscopic damage. Quantitative MRI provides instead feature maps that can be exploited to improve prognosis and treatment monitoring, at the cost of prolonged acquisition times and specialised MR-protocols. In this study, two converging approaches were followed to investigate how to best use the available MRI data for the diagnosis and prognosis of MS. On one hand, qualitative data commonly used in clinical research for lesion and anatomical purposes were shown to carry quantitative information that could be used to conduct myelin and relaxometry analyses on cohorts devoid of dedicated quantitative acquisitions. In this study arm, named bottom-up, qualitative information was up-converted to quantitative surrogate: traditional model-fitting and deep-learning frameworks were proposed and tested on MS patients to extract relaxometry and indirect-myelin quantitative data from qualitative scans. On the other hand, when using multi-modal MRI data to classify MS patients with different clinical status, different MR-features contribute to specific classification tasks. The top-down study arm consisted in using machine learning to reduce the multi-modal dataset dimensionality only to those MR-features that are more likely to be biophysically meaningful with respect to each MS phenotype pathophysiology. Results show that there is much more potential to qualitative data than lesion and tissue segmentation, and that specific MRI modalities might be better suited for investigating individual MS phenotypes. Efficient multi-modal acquisitions informed by biophysical findings, whilst being able to extract quantitative information from qualitative data, would provide huge statistical power through the use of large, historical datasets, as well as constitute a significant step forward in the direction of sustainable research

MRI quantification of multiple sclerosis pathology

Background: Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative disease and a common cause of neurologic disability. MS pathology is characterized by demyelination, neuroaxonal loss and atrophy. Magnetic Resonance Imaging (MRI) is an essential tool in diagnosing and monitoring MS, but its clinical value could be even further expanded by more advanced and quantitative MRI methods, which may also provide additional pathophysiological insights. Purpose: The overall aim of this thesis was to quantify MS pathology using volumetric brain MRI, ultra-high field brain and cervical spinal cord MRI as well as a newly developed rapid myelin imaging technique in relation to cognitive and physical MS disability. Study I, a prospective 17-year longitudinal study of 37 MS participants with 23 age/sex- matched healthy controls for comparison at the last follow-up. Longitudinal volumetric brain 1.5 Tesla MRI during the second half of the study showed that lesion accumulation and corpus callosum atrophy were the most strongly associated neuroanatomical correlates of cognitive disability, with the lesion fraction being an independent predictor of cognitive performance 8.5 years later. Study II, a prospective cross-sectional study of 35 MS participants and 11 age-matched healthy controls using 3 and 7 Tesla MRI. The study demonstrated involvement of both grey and white matter in MS, not only the brain but also the cervical spinal cord, associated with MS disability. Lesions appeared in proximity to the cerebrospinal fluid (CSF), with special predilection to the periventricular and grey matter surrounding the central canal in secondary progressive MS. Study III, a prospective in vivo (71 MS participants and 21 age/sex-matched healthy controls) and ex vivo (brain tissue from 3 MS donors) study at 3 Tesla, showed that a new clinically approved and feasible rapid myelin imaging technique correlates well with myelin stainings and produces robust in vivo myelin quantification that is related to both current and future cognitive and physical disability in MS. Study IV, an in-depth topographical analysis based on Study III, mapped the distribution of demyelination, both in vivo and ex vivo, in the periventricular and perilesional regions of the brain. A gradient of demyelination with predominance near the CSF spaces was seen. Measures of clinical disability were consistently and more strongly associated with the myelin content in normal-appearing tissue compared to the intralesional myelin content. Conclusions: Lesions and atrophy contribute to cognitive and physical disability in MS but to a varying degree, likely dependent on the relative involvement of white vs. grey matter. Both focal lesions/demyelination as well as diffuse demyelination in normal-appearing white matter shows an apparent gradient from the CSF, which differ between relapsing-remitting and progressive MS subtypes/phases. The growing utility and clinical availability of advanced and quantitative MRI techniques holds promise for improved monitoring of MS pathology and likely represents a vital tool for assessing the efficacy of potential remyelinating/reparative therapies in MS

Cortical Morphology and MRI Signal Intensity Analysis in Paediatric Epilepsy

Epilepsy encompasses a great variety of aetiologies, and as such is not a single disease but a group of diseases characterised by unprovoked seizures.The primary aim of the work presented in this thesis was to use multimodal structural imaging to improve understanding of epilepsy related brain pathology, both the epileptogenic lesions themselves and extralesional pathology, in order to improve pre-surgical planning in medicationresistant epilepsy and improve understanding of the underlying pathogenic mechanisms. The work focuses on 2 epilepsy aetiologies: focal cortical dysplasia (FCD) (chapters 2 and 3) and mesial temporal lobe epilepsy (chapters 4 & 5). Chapter 2 of this thesis develops surface-based, structural MRI post-processing techniques that can be applied to clinical T1 and FLAIR images to complement current MRI-based diagnosis of focal cortical dysplasias. Chapter 3 uses the features developed in Chapter 2 within a machine learning framework to automatically detect FCDs, obtaining 73% sensitivity using a neural network. Chapter 4 develops an in vivo method to explore neocortical gliosis in adults with TLE, while Chapter 5 applies this method to a paediatric cohort. Finally, the concluding chapter discusses contributions, main limitations and outlines options for future research

Individualised Clinical Neuroimaging in the Developing Brain: Abnormality Detection

Perinatal neuroanatomical structure is incredibly intricate and, at time of birth, is undergoing continuous change due to interweaving developmental processes (growth, myelination and gyrification). While there is some small variability in structure and rates of development, all follow proscribed pathways with well documented milestones. Brain injury or other disruption of these processes can result in poor neurodevelopmental outcomes or mortality, making their early identification critical to estimate, and potentially forestall, negative effects. MRI is an increasingly used method of investigating suspected neonatal encephalopathies and injuries.Identification of these injuries and malformations is more challenging in neonates compared to adults due to the brain’s continuously evolving appearance. This makes radiological review of neonatal MRI an intensive and time-consuming task which, in an ideal setting, requires a team of highly skilled clinicians and radiologists with complementary training and extensive experience. To assist this review process, some localisation method that highlights areas likely to contain tissue abnormalities would be highly desirable, as it could quickly draw attention to these locations. In addition, identifying neonates whose MRI is likely to contain some form of pathology could allow for review prioritisation.In this thesis, I first investigated using normative models of neonatal tissue intensity for brain tissue abnormality detection. I applied voxel-wise Gaussian process (GP) regression to a training cohort of neonates with no obvious lesions, all born preterm (<37 weeks) but imaged between 28-55 weeks. Gestational age at birth (GA), postmenstrual age at scan (PMA) and sex were used as input variables and voxel intensity as the output variable. GPs output a mean value and its variance inferred from neonates within the training cohort whose demographic information most closely matched those of the prediction target. The voxel specific models were put together to form a synthesised typical image and standard deviation image derived from the variance outputs. Z-score abnormality maps were constructed by taking the difference between neonates actual MRI and GP-calculated synthetic image and scaling by their standard deviation map. Higher Z-score map values indicate voxels more likely to contain abnormal tissue intensity. Using manually delineated masks of common brain injuries seen in a subset of neonates, these abnormality Z-score maps demonstrated good detection performance using area under the curve of receiver operating characteristic scores, with the exception of small punctate lesions.The initial voxel-wise models had substantial false positives around the edges of the brain where there is large typical heterogeneity. I next investigated if incorporating local structural information into predictive models could improve their ability to accommodate typical anatomical heterogeneity seen across individual brains and improve the accuracy of synthetic images and abnormality detection. To achieve this, voxel intensity values in a patch surrounding the prediction target were appended to the design matrix, alongside GMA, PMA and sex. The patch-based synthetic images were able to match an individual’s brain structure more closely and had lower false positives in normal appearing tissue. However, a weakness was that the centre of some larger lesions was included in the predictions (thereby classified as ‘healthy’ tissue), having a deleterious effect on their coverage, increasing false negatives. This was offset by much better coverage of smaller, more subtle lesions, to the extent that overall performance was higher compared to that seen in the earlier model.I also investigated if the Z-score abnormality maps could be used to classify neonates with MRI positive brain injury from those with normal appearing brains. While many machine learning algorism see frequent use in neuroimaging classification tasks, I opted for a logistic regression model due to its high levels of interpretability and simple implementation. Using the histograms of the Z-score abnormality maps as inputs, the model demonstrated good performance, being able to correctly identify neonates with injuries, but not those with subtle lesions like punctate lesions, whilst minimising false identification of neonates with normal appearing brains.To ascertain if performance could be improved, I explored multiple classification methods. Specifically, the use of other more complex classifiers (random forest, support vector machines, GP classification) and the use of a regional abnormal voxel count, that allowed localisation of lesioned tissue rather than the more global detection ability of the Z-score histograms. Using these innovations, I investigated their application towards a specific pathology; hypoxic ischemic encephalopathy (HIE). This is a good test for the system, as HIE has high incidence rates, multiple associated lesion types and a time dependant appearance. Further, I wanted to know if, given a positive HIE diagnosis, the Z-score abnormality maps could be used to predict long-term outcomes (normal vs poor). Several models demonstrated an excellent ability to separate HIE and healthy control neonates achieving >90% accuracy, a statistically significant result even after false discovery rate (FDR) correction (p-value < 0.05). While the outcome prediction models achieved reasonable accuracy, >70% in multiple models, none of these were statistically significant after FDR correction.Overall, this work demonstrates how normative modelling can be used to create individual voxel-wise / image-wise estimation of tissue abnormality for neonatal MRI across a range of gestational ages. It further demonstrates that these abnormality maps can be utilised for additional tasks, in this instance, three increasingly challenging neurological classification problems. These include the separation of neonates with and without MRI positive lesions, identification of neonates with a specific pathological condition (HIE) and prediction of long-term functional outcome (normal vs poor). Within a radiological setting, these classifications task can be considered analogous to three radiological challenges, image triage, diagnostic detection and estimation of developmental prognosis, important for the clinical team but also infants and their families

Advanced Sensing and Image Processing Techniques for Healthcare Applications

This Special Issue aims to attract the latest research and findings in the design, development and experimentation of healthcare-related technologies. This includes, but is not limited to, using novel sensing, imaging, data processing, machine learning, and artificially intelligent devices and algorithms to assist/monitor the elderly, patients, and the disabled population

Recommendations and guidelines from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 1 -- In vivo small-animal imaging

The value of in vivo preclinical diffusion MRI (dMRI) is substantial. Small-animal dMRI has been used for methodological development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. Many of the influential works in this field were first performed in small animals or ex vivo samples. The steps from animal setup and monitoring, to acquisition, analysis, and interpretation are complex, with many decisions that may ultimately affect what questions can be answered using the data. This work aims to serve as a reference, presenting selected recommendations and guidelines from the diffusion community, on best practices for preclinical dMRI of in vivo animals. In each section, we also highlight areas for which no guidelines exist (and why), and where future work should focus. We first describe the value that small animal imaging adds to the field of dMRI, followed by general considerations and foundational knowledge that must be considered when designing experiments. We briefly describe differences in animal species and disease models and discuss how they are appropriate for different studies. We then give guidelines for in vivo acquisition protocols, including decisions on hardware, animal preparation, imaging sequences and data processing, including pre-processing, model-fitting, and tractography. Finally, we provide an online resource which lists publicly available preclinical dMRI datasets and software packages, to promote responsible and reproducible research. An overarching goal herein is to enhance the rigor and reproducibility of small animal dMRI acquisitions and analyses, and thereby advance biomedical knowledge.Comment: 69 pages, 6 figures, 1 tabl

Advanced MRI methods for probing disease severity and functional decline in multiple sclerosis

Multiple sclerosis (MS) is a chronic and severe disease of the central nervous system characterized by complex pathology including inflammatory demyelination and neurodegeneration. MS impacts >2.8 million people worldwide, with most starting with a relapsing-remitting form (RRMS) in young adulthood, and many of them worsening to a secondary-progressive course (SPMS) despite treatment. So, there is a clear need for improved disease characterization. MRI is an ideal tool for non-invasive assessment of MS pathology, but there is still no established measure of disease activity and functional consequences. This project aims to overcome the challenge by developing novel imaging measures based on brain diffusion MRI and phase congruency texture analysis of conventional MRI. Through advanced modeling and analysis of clinically feasible brain MRI, this thesis investigates whether and how the derived measures differentiate MS pathology types and disease severity and predict functional outcomes in MS. The overall process has led to important technical innovations in several aspects. These include: innovative modeling of simple diffusion acquisitions to generate high angular resolution diffusion imaging (HARDI) measures; new optimization and harmonization techniques for diffusion MRI; innovative neural network models to create new diffusion data for comprehensive HARDI modeling; and novel methods and a graphic user interface for optimizing phase congruency analyses. Assisted by different machine learning methods, collective findings show that advanced measures from both diffusion MRI and phase congruency are highly sensitive to subtle differences in MS pathology, which differentiate disease severity between RRMS and SPMS through multi-dimensional analyses including chronic active lesions, and predict functional outcomes especially in physical and neurocognitive domains. These results are clinically translational and the new measures and techniques can help improve the evaluation and management of both MS and similar diseases

Simultaneous Multiparametric and Multidimensional Cardiovascular Magnetic Resonance Imaging

No abstract available